{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:31:27Z","timestamp":1787315487365,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20140223"],"award-info":[{"award-number":["BK20140223"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20140225"],"award-info":[{"award-number":["BK20140225"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703359"],"award-info":[{"award-number":["81703359"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402789"],"award-info":[{"award-number":["81402789"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ejmech.2017.12.042","type":"journal-article","created":{"date-parts":[[2017,12,16]],"date-time":"2017-12-16T13:02:42Z","timestamp":1513429362000},"page":"424-434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Design, synthesis and evaluation of novel phenyl propionamide derivatives as non-nucleoside hepatitis B virus inhibitors"],"prefix":"10.1016","volume":"144","author":[{"given":"Jingying","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qineng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinpeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoke","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoquan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.12.042_bib1","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/ijc.30553","article-title":"HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K\/AKT signal pathway","volume":"140","author":"Zhu","year":"2017","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.ejmech.2017.12.042_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.virol.2016.12.017","article-title":"Recapitulation of treatment response patterns in a novel humanized mouse model for chronic hepatitis B virus infection","volume":"502","author":"Winer","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.ejmech.2017.12.042_bib3","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2016.05.029","article-title":"Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound","volume":"65","author":"Wang","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ejmech.2017.12.042_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.virusres.2015.12.014","article-title":"Recent developments in antivirals against hepatitis B virus","volume":"213","author":"Wang","year":"2016","journal-title":"Virus Res."},{"key":"10.1016\/j.ejmech.2017.12.042_bib5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/jgh.13191","article-title":"Efficacy of interferon for chronic hepatitis B in patients with nucleoside and nucleotide combination therapy failure","volume":"31","author":"Yin","year":"2016","journal-title":"J.\u00a0Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2017.12.042_bib6","doi-asserted-by":"crossref","first-page":"12558","DOI":"10.3748\/wjg.v21.i44.12558","article-title":"Hepatitis B virus therapy: what's the future holding for us?","volume":"21","author":"Manzoor","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejmech.2017.12.042_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12250-014-3410-5","article-title":"New therapeutic vaccination strategies for the treatment of chronic hepatitis B","volume":"29","author":"Liu","year":"2014","journal-title":"Virol. Sin."},{"key":"10.1016\/j.ejmech.2017.12.042_bib8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejmech.2016.07.048","article-title":"Design, synthesis and evaluation of pyrazole derivatives as non-nucleoside hepatitis B virus inhibitors","volume":"123","author":"Jia","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.042_bib9","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1016\/j.bmc.2009.03.003","article-title":"Synthesis and anti-hepatitis B virus activities of Matijing-Su derivatives","volume":"17","author":"Xu","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.042_bib10","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1016\/j.bmc.2011.08.001","article-title":"Synthesis and biological evaluation of Matijing-Su derivatives as potent anti-HBV agents","volume":"19","author":"Qiu","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.042_bib11","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/cbdv.201600113","article-title":"Synthesis and biological evaluation of Matijin-Su derivatives as potential antihepatitis B virus and anticancer agents","volume":"13","author":"Qiu","year":"2016","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2017.12.042_bib12","doi-asserted-by":"crossref","first-page":"9592","DOI":"10.1016\/j.tet.2014.11.019","article-title":"Development of a practical and scalable synthesis of anti-HBV drug Y101","volume":"70","author":"Hu","year":"2014","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2017.12.042_bib13","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.str.2013.06.013","article-title":"Assembly-directed antivirals differentially bind quasiequivalent pockets to modify hepatitis B virus capsid tertiary and quaternary structure","volume":"21","author":"Katen","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2017.12.042_bib14","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1128\/AAC.01766-12","article-title":"Phase diagrams map the properties of antiviral agents directed against hepatitis B virus core assembly","volume":"57","author":"Li","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2017.12.042_bib15","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1016\/j.bmcl.2011.05.077","article-title":"Phenylpropenamide derivatives: anti-hepatitis B virus activity of the Z isomer, SAR and the search for novel analogs","volume":"21","author":"Wang","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"28","key":"10.1016\/j.ejmech.2017.12.042_bib16","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/hep.510280432","article-title":"Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus","author":"Delaney","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2017.12.042_bib17","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1021\/jm101325h","article-title":"Design and synthesis of oxymatrine analogues overcoming drug resistance in hepatitis B virus through targeting host heat stress cognate 70","volume":"54","author":"Gao","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.042_bib18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.antiviral.2014.04.002","article-title":"Benzimidazole derivative, BM601, a novel inhibitor of hepatitis B virus and HBsAg secretion","volume":"107","author":"Xu","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2017.12.042_bib19","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.1128\/AAC.01558-15","article-title":"A\u00a0novel pyridazinone derivative inhibits hepatitis B virus replication by inducing genome-free capsid formation","volume":"59","author":"Wang","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2017.12.042_bib20","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1053\/jhep.2002.35070","article-title":"Inhibitory activity of dioxolane purine analogs on wild-type and lamivudine-resistant mutants of hepadnaviruses","volume":"36","author":"Seigneres","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2017.12.042_bib21","unstructured":"SYBYL_X2.1 Is Availabe from Tripos Associates Inc., S. H. R., St. Louis, MO 631444, USA."},{"key":"10.1016\/j.ejmech.2017.12.042_bib22","doi-asserted-by":"crossref","first-page":"15196","DOI":"10.1073\/pnas.1513803112","article-title":"High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein","volume":"112","author":"Klumpp","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417310759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417310759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T02:37:01Z","timestamp":1535164621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417310759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":22,"alternative-id":["S0223523417310759"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.12.042","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and evaluation of novel phenyl propionamide derivatives as non-nucleoside hepatitis B virus inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.12.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}